Profile: Greatbatch Inc (GB)

GB on New York Consolidated

23 Jan 2015
Change (% chg)

$1.00 (+2.04%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Greatbatch, Inc. (Greatbatch), incorporated in 1997, is developer and manufacturer of components for implantable medical devices (IMDs) and Electrochem batteries. The Company operates in two segments: Greatbatch Medical and Electrochem Solutions (Electrochem). The Company’s customers include large multi-national original equipment manufacturers (OEMs). The Greatbatch Medical segment designs and manufactures medical devices and components primarily for the cardiac rhythm management (CRM), neuromodulation, vascular access and orthopaedic markets. In addition, Greatbatch Medical offers assembly and design engineering services for products that incorporate Greatbatch Medical components. Electrochem segment provides technology solutions. In August 2014, the Company acquired CCC Medical Devices (CCC), globally-respected active implantable medical device (AIMD) systems developer and manufacturer.

Greatbatch Medical

Greatbatch Medical offers Greatbatch’s customers medical devices including design, development, manufacturing, regulatory submission and supporting worldwide distribution. This medical device strategy is being facilitated through the QiG Group and leverages the component technology of Greatbatch Medical and Electrochem in its markets: Cardiovascular, Neuromodulation and Orthopaedic. Once the QiG Group designs and develops a medical device, it is manufactured by Greatbatch Medical. CRM and Neuromodulation component products include batteries, capacitors, filtered and unfiltered feedthroughs, engineered components, implantable stimulation leads and enclosures used in implantable medical devices (IMD). In addition, Greatbatch Medical offers assembly for these IMDs.

An IMD is an instrument that is surgically inserted into the body to provide diagnosis and/or therapy. One sector of the IMD market is CRM, which is consists of devices, such as implantable pacemakers, implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy (CRT) devices, and cardiac resynchronization therapy with backup defibrillation devices (CRT-D). Another sector of the IMD market is neuromodulation, which is consists of pacemaker-type devices that stimulate nerves for the treatment of various conditions. The Company’s investments in research and development have generated products, such as the QHR QMR and QCapacitor primary battery and capacitor lines. Greatbatch Medical’s Xcellion line of Lithium-Ion rechargeable batteries leverages decades of implantable battery research, development and manufacturing expertise. This line of cells includes the optional CoreGuard feature, which enables batteries to discharge to zero volts without performance degradation.

Vascular Access products include introducers, specialty medical coatings, steerable sheaths and catheters that deliver therapies for many end-user markets including coronary and neurovascular disease, peripheral vascular disease, interventional radiology, vascular access, atrial fibrillation, and interventional cardiology, as well as products for medical imaging and drug and pharmaceutical delivery. Orthopaedic products include hip and shoulder joint reconstruction implants, bone plates and spinal devices, and instruments and delivery systems used in hip and knee replacement, trauma fixation and spine surgeries. Orthopaedic implants are used in reconstructive surgeries to replace or repair hips, knees and other joints, such as shoulders, ankles and elbows that have deteriorated as a result of disease or injury.


Electrochem provides technology solutions. Electrochem’s customized primary (non-rechargeable) and secondary (rechargeable) battery solutions are used in markets, such as energy, portable medical, military, environmental and more. Electrochem’s product lines cover a number of battery-powered applications in remote and demanding environments, including down hole drilling tools, military communication devices, automated external defibrillators, oceanographic buoys and more. Electrochem’s primary and secondary power solutions and wireless sensing systems are used in markets where failure is not an option.

The Company’s primary lithium power solutions are utilized in extreme climates. Electrochem’s product designs incorporate protective circuitry, glass-to-metal hermetic seals, fuses and diodes to help ensure safe, durable and reliable power as devices are subjected to these harsh conditions. Its secondary power solutions consist of number of chemistries including lithium, nickel and lead acid. Electrochem’s wireless sensing solutions provide real-time control and monitoring in markets where wired sensors can be hazardous and impractical, as well as industrial environments that possess dirty, remote and extreme environmental conditions.

The Company competes with Biotronik, Boston Scientific, Johnson & Johnson, Medtronic, Smith & Nephew, Sorin Group, St. Jude Medical, Stryker, Zimmer, Eagle-Picher, Quallion, Critical Medical Components, The Morgan Crucible Co. PLC, Kyocera, Eurofarad, Heraeus, Hudson, National, Numerous, Creganna, Teleflex, Pressure Products, Thomas Medical, Oscor, Accelent, Avalign Technologies, IMDS, Micropulse, Inc., Norwood Medical, Orchid, Sandvik, Symmetry, Paragon, Tracer Technologies, Engineered Power, Saft, Ultralife, ICC, Nexergy and Vektek.

Company Address

Greatbatch Inc

FRISCO   TX   75034
P: +1716.7595600
F: +1302.6555049

Company Web Links

Search Stocks